Navigation Links
11 Pharmaceutical Titans Headline Chemistry Outsourcing Conference Program in September in New Jersey

LONG BRANCH, N.J., May 15 /PRNewswire/ -- Chemical sourcing executives from the eleven largest pharmaceutical companies will gather to discuss timely issues during the Pharma ChemOutsourcing Conference on September 8-9 in New Jersey. This is the first time that such an impressive gathering of industry management has met to exchange viewpoints on the rapidly globalizing web of materials and services to support R & D activities.

The speakers will represent Abbott Labs, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Schering-Plough, and Wyeth.

The industry sourcing leaders speakers will discuss during panel sessions themselves a wide cadre of topics that will feature speakers from mid-sized and smaller pharmaceutical companies, too. The 95-speaker conference speaker faculty hail from many pharma companies and some suppliers. The conference program may be viewed at

Attendees, exhibitors, and speakers hail from the USA, United Kingdom, India, Germany, Canada, Belgium, Russia, Italy, and a dozen other countries.

1,000 attendees and 100 custom synthesis and other service providers are registered; the current roster is at

Panel discussion topics include:

* Raw material and API sourcing

* Supplier performance metrics

* New regulations in Asia and the cost of sourcing

* Biotech small molecule sourcing needs

* Sourcing synthetic routes & process optimization

* Phase II and commercial sourcing and manufacturing

* Discovery and medicinal chemistry outsourcing models

Overall, 21 such panel discussions are scheduled during the two-day event. Exploding interest in chemical outsourcing activities have shaped the 2008 ChemOutsourcing event into an international meeting place to accommodate the industry need for information and networking, reports Apaporis LLC.

For more information, contact the organizer, Mark Alexay at, 201.452.4023, or visit .

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: